Avidity Biosciences Inc.

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.

Investing News NetworkYour trusted source for investing success

13 Canadian Crypto ETFs (Updated 2024)

When is the Starlink IPO Date and Can You Invest? (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

Leigh Goehring: Gold's "Massive Bull Market" Just Starting; Uranium and Copper Outlook

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

How Could Trump's US Election Win Affect the Gold Price?

Top 4 Largest Lithium Reserves by Country (Updated 2024)

McDermitt PFS Demonstrates Multi-Decade Competitive Source of US Lithium Carbonate

OSISKO METALS EXPANDS LEADERSHIP TEAM AND ANNOUNCES C$100 MILLION BOUGHT DEAL FINANCING

Osisko Metals Announces Significant Increase in Mineral Resources at Gaspé Copper

Silver47 Drills 2.48m of 14.95 g/t Gold, 249.50 g/t Silver, 21.97% Zinc, 7.03% Lead, 0.42% Copper at Its Red Mountain Project, Alaska

Production and Revenue Growth at Alta Mesa Uranium Project, Texas

Announcement by Cyclone Metals Ltd

Silver47 Exploration

Purpose Bitcoin ETF

Osisko Metals: Leading the Charge in Base Metal Investments

Syntheia

2024 Gold Outlook Report

2024 Lithium Market Outlook

2024 AI Market Outlook Report

Silver Price Forecast - What Happened And Where Do We Go From Here?

Avidity Biosciences Inc.

Stem Cell Stocks: 10 Biggest NASDAQ Companies

5 US Longevity and Anti-aging Stocks to Watch in 2024

Interactive Chart